| |
|
|
Sam Sung Pharm.Ind. (001360) |
|
|
STOCK |
|
|
|
  |
(unit : Won, Share) |
| Fiscal Year End |
04.12 | 05.12 | 06.12 | 07.06 |
| Par Value |
5,000 | 5,000 | 5,000 | 5,000 |
| Yearly Highest Price |
6,500 | 6,800 | 5,370 | 4,900 |
| Yearly Lowest Price |
3,125 | 3,340 | 3,435 | 3,710 |
| Common Shares O/S |
5,589,733 | 5,589,733 | 7,589,733 | 7,589,733 |
| Preferred Shares O/S |
- | - | - | - |
| Market Cap.(100Mn.Won) |
200 | 276 | 354 | 337 |
| Dividends (%) |
- | - | - | - |
|
 |
(Company/Sector/Market) |
| |
2006.06 | 2007.06 |
| Beta |
0.92 / 0.92 / 1.00 | 0.60 / 0.72 / 1.00 |
| Volatility |
57.97 / 30.84 / 19.70 | 37.24 / 19.70 / 14.26 |
|
 |
(unit : Won) |
| Fiscal Year End |
04.12 | 05.12 | 06.12 | 07.06 |
| Earnings Per Share |
- 57 | - 1,693 | - 2,056 | 168 |
| Sales Per Share |
5,130 | 4,943 | 4,894 | 4,223 |
| Book Value Per Share |
5,959 | 4,297 | 2,892 | 2,977 |
| Cash Flow Per Share |
188.69 | 101.72 | - 221.48 | - 195.46 |
|
 |
(Unit : Times) |
| Fiscal Year End |
04.12 | 05.12 | 06.12 | 07.06 |
| Price / Earnings (H/L) |
-/- | -/- | -/- | 29.17/22.08 |
| Price / Sales (H/L) |
1.27/0.61 | 1.38/0.68 | 1.10/0.70 | 1.16/0.88 |
| Price / Book (H/L) |
1.09/0.52 | 1.58/0.78 | 1.86/1.19 | 1.65/1.25 |
| Price / Cash Flow (H/L) |
34.45 / 16.56 | 66.85 / 32.84 | - /- | - /- |
|
 |
(Unit : 100Mn.Won, %) |
| Fiscal Year End |
03.12 |
04.12 |
05.12 |
06.12 |
| Company |
Sector |
Company |
Sector |
Company |
Sector |
Company |
Sector |
| Invested Capital |
627 |
723 |
617 |
718 |
597 |
756 |
611 |
- |
| NOPLAT |
- 4 |
48 |
5 |
80 |
2 |
72 |
- 32 |
- |
| Return on Invested Capital |
- 0 |
6 |
0 |
11 |
0 |
9 |
- 5 |
- |
| WACC |
6 |
6 |
6 |
6 |
7 |
6 |
7 |
- |
| Economic Value Added |
- 47.1 |
2.5 |
- 34.6 |
37.5 |
- 40.7 |
23.1 |
- 81.0 |
- |
|
 |
(Unit : 100Mn.Won, Times) |
| Fiscal Year End |
2004.12 | 2005.12 | 2006.12 | 2007.06 |
| Enterprise Value(EV) |
376.72 | 454.00 | 458.44 | 496.75 |
| EBITDA |
18.42 | - 38.73 | - 93.79 | 33.89 |
| EBITDA/Sales |
0.06 | - 0.14 | - 0.33 | 0.11 |
| EBITDA/Financial Exp. |
1.32 | - 2.67 | - 5.72 | 2.45 |
| EV/EBITDA |
20.46 | - | - | 14.66 |
|
|
|
|
